The DOI matches its Crossref record; 549 of the 549 references it cites were found in a registry or an index.
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
Open accessAbstract
Polycystic ovary syndrome (PCOS) was hypothesized to result from functional ovarian hyperandrogenism (FOH) due to dysregulation of androgen secretion in 1989 -1995.Subsequent studies have supported and amplified this hypothesis.When defined as otherwise unexplained hyperandrogenic oligoanovulation, two-thirds of PCOS cases have functionally typical FOH, characterized by 17-hydroxyprogesterone hyperresponsiveness to gonadotropin stimulation.Two-thirds of the remaining PCOS have FOH detectable by testosterone elevation after suppression of adrenal androgen production.About 3% of PCOS have a related isolated functional adrenal hyperandrogenism.The remaining PCOS cases are mild and lack evidence of steroid secretory abnormalities; most of these are obese, which we postulate to account for their atypical PCOS.Approximately half of normal women with polycystic ovarian morphology (PCOM) have subclinical FOH-related steroidogenic defects.Theca cells from polycystic ovaries of classic PCOS patients in long-term culture have an intrinsic steroidogenic dysregulation that can account for the steroidogenic abnormalities typical of FOH.These cells overexpress most steroidogenic enzymes, particularly cytochrome P450c17.Overexpression of a protein identified by genome-wide association screening, differentially expressed in normal and neoplastic development 1A.V2, in normal theca cells has reproduced this PCOS phenotype in vitro.A metabolic syndrome of obesity-related and/or intrinsic insulin resistance occurs in about half of PCOS patients, and the compensatory hyperinsulinism has tissue-selective effects, which include aggravation of hyperandrogenism.PCOS seems to arise as a complex trait that results from the interaction of diverse genetic and environmental factors.Heritable factors include PCOM, hyperandrogenemia, insulin resistance, and insulin secretory defects.Environmental factors include prenatal androgen exposure and poor fetal growth, whereas acquired obesity is a major postnatal factor.The variety of pathways involved and lack of a common thread attests to the multifactorial nature and heterogeneity of the syndrome.Further research into the fundamental basis of the disorder will be necessary to optimally correct androgen levels, ovulation, and metabolic homeostasis.(Endocrine Reviews 37: 467-520, 2016) I. Historical Perspective II.Definition of Polycystic Ovary Syndrome (PCOS) III.Normal Androgen Physiology A. Biochemical and molecular overview of steroidogenesis B. Regulation of ovarian function 1. Regulation of gonadotropin secretion 2. Regulation of ovarian steroidogenesis a. Homologous desensitization to LH b.Modulation of LH action 3. Folliculogenesis and its regulation C. Regulation of adrenal androgen production D. Regulation of peripheral androgen production E. Summary of normal androgen physiology IV.Source of Androgen Excess in PCOS A. Testing to determine the source of androgen in PCOS B. Functional Ovarian Hyperandrogenism (FOH) in PCOS 1. Spectrum of ovarian androgenic function in PCOS: Typical and atypical FOH 2. Spectrum of ovarian androgenic function in asymptomatic women with polycystic ovarian morphology (PCOM)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elevated ovarian androgen production is a core feature of PCOS and results in PCOS symptoms including hair loss, acne, oily skin, and accumulation of abdominal fat (Rosenfield & Ehrmann, 2016).”
From Endometriosis and polycystic ovary syndrome are diametric disorders (2021) · cites this paper as Rosenfield & Ehrmann, 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dietary and environmental factors are hypothesized to have an impact on developmental programming of susceptible gene variants in women with PCOS [41,42,43].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Insulin resistance (IR) is not the leading cause of obesity, although obesity really does worsen the insulin resistance of polycystic ovarian syndrome (PCOS) and hyperandrogenemia.”
From Nutritional and herbal interventions for polycystic ovary syndrome (PCOS): a comprehensive review of dietary approaches, macronutrient impact, and herbal medicine in management (2025) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This research has resulted in a proposed “two hit” hypothesis for the development of PCOS phenotypes [43,45].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“Hyperinsulinism can appear due to insulin resistance and be caused by the production of chemical substances that are metabolically active by the visceral adipose tissue [63].”
In the citing paper
“Visceral adiposity in PCOS is associated with increased IR, leading to exacerbation of reproductive and metabolic abnormalities [23].”
From PCOS and nutritional approaches: Differences between lean and obese phenotype (2021) · cites this paper as [23]
In the citing paper
“Additionally, obesity significantly impacts the PCOS phenotype since it is associated with a higher prevalence of menstrual irregularity, hyperandrogenemia, and hirsutism [23].”
From PCOS and nutritional approaches: Differences between lean and obese phenotype (2021) · cites this paper as [23]
In the citing paper
“In turn, androgens promote visceral fat accumulation and IR by inhibiting lipolysis and promoting lipogenesis.”
From PCOS and nutritional approaches: Differences between lean and obese phenotype (2021) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Obesity Is Associated with Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland
Subbaramaiah, K., Howe, L. R., Bhardwaj, P., Du, B., Gravaghi, C., Yantiss, R. K., Zhou, X. K., Blaho, V. A., Hla, T., Yang, P., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0381 · Cited by 362
RetractedMatthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,770
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,308
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Eckel, R. H., Grundy, S. M., & Zimmet, P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,693
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Self-citationPersistent epigenetic differences associated with prenatal exposure to famine in humans
Heijmans, B. T., Tobi, E. W., Stein, A. D., Putter, H., Blauw, G. J., Susser, E. S., Slagboom, P. E., & Lumey, L. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806560105 · Cited by 3,082
Elective induction versus spontaneous labor after sonographic diagnosis of fetal macrosomia.
Combs, C. A., Singh, N. B., & Khoury, J. C. (1993) · PubMed · Cited by 2,462
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458 · cited 13×
“do not do so because they do not express CYP17A1 (62).”
BackgroundInfluentialWhat we talk about when we talk about fat
Rosen, E. D., & Spiegelman, B. M. (2014) · Cell · doi:10.1016/j.cell.2013.12.012 · Cited by 2,373
Consensus Statement on Management of Intersex Disorders
Lee, P. A., Houk, C. P., Ahmed, S. F., Hughes, I. A., & in collaboration with the participants in the International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology (2006) · Pediatrics · doi:10.1542/peds.2006-0738 · Cited by 2,324
Men at risk: occupation and male infertility.
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,219
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045
Fetal origins of adult disease: strength of effects and biological basis
Barker, D., Eriksson, J., Forsén, T., & Osmond, C. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.6.1235 · Cited by 2,024
Fauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Ehrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,884
Self-citationAromatase Cytochrome P450, The Enzyme Responsible for Estrogen Biosynthesis*
SIMPSON, E. R., Mahendroo, M., Means, G., Kilgore, M. W., Hinshelwood, M. M., Graham-Lorence, S. E., Amarneh, B., Ito, Y., Fisher, C. R., Michael, M. D., et al. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-342 · Cited by 1,542
Regulation of ovarian follicular development in primates: facts and hypotheses
GOUGEON, A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-121 · Cited by 1,497
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
Metformin—mode of action and clinical implications for diabetes and cancer
Pernicova, I., & Korbonits, M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.256 · Cited by 1,390
Global Disorders of Sex Development Update since 2006: Perceptions, Approach and Care
Lee, P. A., Nordenström, A., Houk, C. P., Ahmed, S. F., Auchus, R. J., Baratz, A. B., Dalke, K. B., Liao, L., Lin‐Su, K., Looijenga, L. H. J., et al. (2016) · Hormone Research in Paediatrics · doi:10.1159/000442975 · Cited by 1,292
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Self-citationGrundy, S. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,227
Lipid-induced insulin resistance: unravelling the mechanism
Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60408-4 · Cited by 1,189
Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176
Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132
Control of Primordial Follicle Recruitment by Anti-Mullerian Hormone in the Mouse Ovary
Durlinger, A. L. L., Kramer, P., Karels, B., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (1999) · Endocrinology · doi:10.1210/endo.140.12.7204 · Cited by 1,075
The physiology and clinical utility of anti-Müllerian hormone in women
Dewailly, D., Andersen, C. Y., Balen, A. H., Broekmans, F. J., Dilaver, N., Fanchin, R. R. F., Griesinger, G., Kelsey, T., Marca, A. L., Lambalk, C. B., et al. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt062 · Cited by 1,056
Ultrasound assessment of the polycystic ovary: international consensus definitions
Balen, A. H., Laven, J. S. E., Tan, S.-L., & Dewailly, D. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg044 · Cited by 1,015
Suppression of Ovarian Follicle Activation in Mice by the Transcription Factor Foxo3a
Castrillón, D. H., Miao, L., Kollipara, R., Horner, J. W., & DePinho, R. A. (2003) · Science · doi:10.1126/science.1086336 · Cited by 984
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Apridonidze, T., Essah, P. A., Iuorno, M. J., & Nestler, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1045 · Cited by 931
Kiddy, D. S., Hamilton‐Fairley, D., Bush, A., Short, F., Anyaoku, V., Reed, M. J., & Franks, S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02909.x · Cited by 921
POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
POLSON, D. W., Wadsworth, J., Adams, J., & Franks, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91612-1 · Cited by 899
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
Insulin resistance during puberty: results from clamp studies in 357 children.
Moran, A., Jacobs, D. R., Steinberger, J., Hong, C. P., Prineas, R. J., Luepker, R. V., & Sinaiko, A. R. (1999) · Diabetes · doi:10.2337/diabetes.48.10.2039 · Cited by 869
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Miller, R., Chu, Q., Xie, J., Foretz, M., Viollet, B., & Birnbaum, M. J. (2013) · Nature · doi:10.1038/nature11808 · Cited by 845
Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children
Carel, J., Eugster, E. A., Rogol, A. D., Ghizzoni, L., Palmert, M. R., & on behalf of the members of the ESPE-LWPES GnRH Analogs Consensus Conference Group (2009) · PEDIATRICS · doi:10.1542/peds.2008-1783 · Cited by 816
NESTLER, J. E., POWERS, L. P., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., RITTMASTER, R. S., CLORE, J. N., & BLACKARD, W. G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-83 · Cited by 815
Nestler, J. E., Jakubowicz, D. J., Evans, W. S., & Pasquali, R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806253382603 · Cited by 781
Stepto, N. K., Cassar, S., Joham, A. E., Hutchison, S. K., Harrison, C. L., Goldstein, R. F., & Teede, H. J. (2013) · Human Reproduction · doi:10.1093/humrep/des463 · Cited by 747
Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743
Schmidt, D., Ovitt, C., Anlag, K., Fehsenfeld, S., Gredsted, L., Treier, A.-C., & Treier, M. (2004) · Development · doi:10.1242/dev.00969 · Cited by 740
Androgens stimulate early stages of follicular growth in the primate ovary
Vendola, K. A., Zhou, J., Adesanya, O. O., Weil, S. J., & Bondy, C. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2081 · Cited by 712
The Importance of -Cell Failure in the Development and Progression of Type 2 Diabetes
Kahn, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7713 · Cited by 709
Intraovarian Control of Early Folliculogenesis
Hsueh, A. J. W., Kawamura, K., Cheng, Y., & Fauser, B. C. J. M. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1020 · Cited by 708
Insulin resistance in nonobese patients with polycystic ovarian disease
CHANG, R. J., NAKAMURA, R. M., JUDD, H. L., & KAPLAN, S. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-356 · Cited by 704
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
Legro, R. S., Driscoll, D., Strauss, J. F., Fox, J., & Dunaif, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14956 · Cited by 699
Tang, T., Lord, J. M., Norman, R. J., Yasmin, E., & Balen, A. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053.pub5 · Cited by 698
Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome
Shi, Y., Zhao, H., Shi, Y., Cao, Y., Yang, D., Li, Z., Zhang, B., Liang, X., Li, T., Chen, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2384 · Cited by 678
Heritability of polycystic ovary syndrome in a Dutch twin-family study
Vink, J. M., Sadrzadeh, S., Lambalk, C. B., & Boomsma, D. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1494 · Cited by 647
Barbieri, R. L., Makris, A., Randall, R. W., Daniels, G. H., Kistner, R. W., & Ryan, K. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-904 · Cited by 629
Nestler, J. E., Jakubowicz, D. J., Falcon de Vargas, A., Brik, C., Quintero, N., & Medina, F. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4886 · Cited by 617
WHO recognition of the global obesity epidemic
James, W. P. T. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.247 · Cited by 615
Altered Cardiovascular Variability in Obstructive Sleep Apnea
Narkiewicz, K., Montano, N., Cogliati, C. B., van de Borne, P. J. H., Dyken, M. E., & Somers, V. K. (1998) · Circulation · doi:10.1161/01.cir.98.11.1071 · Cited by 607
Intraadrenal interactions in the regulation of adrenocortical steroidogenesis.
Ehrhart-Bornstein, M., Hinson, J. P., Bornstein, S. R., Scherbaum, W. A., & Vinson, G. P. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.2.0326 · Cited by 600
Postnatal Sex Reversal of the Ovaries in Mice Lacking Estrogen Receptors α and β
Couse, J. F., Hewitt, S. C., Bunch, D. O., Sar, M., Walker, V. R., Davis, B. J., & Korach, K. S. (1999) · Science · doi:10.1126/science.286.5448.2328 · Cited by 594
Androgen and follicle stimulating hormone interactions in primate ovarian follicle development
Weil, S., Vendola, K., Zhou, J., & Bondy, C. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5929 · Cited by 592
DeUgarte, C. M., Bartolucci, A. A., & Azziz, R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.070 · Cited by 589
Follicle dynamics and anovulation in polycystic ovary syndrome
Franks, S., Stark, J., & Hardy, K. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn015 · Cited by 581
Nelson, V. L., Legro, R. S., Strauss, J. F., & McAllister, J. M. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0311 · Cited by 556
Dewailly, D., Lujan, M. E., Carmina, E., Cedars, M. I., Laven, J., Norman, R. J., & Escobar-Morreale, H. F. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt061 · Cited by 551
Taylor, A. E., McCourt, B. J., Martin, K. A., Anderson, E. J., Adams, J. M., Schoenfeld, D., & Hall, J. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4105 · Cited by 544
Evidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary Syndrome
Dunaif, A. E., Segal, K. R., Shelley, D., Green, G., Dobrjansky, A., & Licholai, T. (1992) · Diabetes · doi:10.2337/diab.41.10.1257 · Cited by 544
POLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVE
Franks, S. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb00457.x · Cited by 523
Formation and early development of follicles in the polycystic ovary
Webber, L. J., Stubbs, S. A., Stark, J., Trew, G. H., Margara, R. A., Hardy, K., & Franks, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14410-8 · Cited by 521
Granulosa Cell Production of Anti-Müllerian Hormone Is Increased in Polycystic Ovaries
Pellatt, L. J., Hanna, L., Brincat, M., Galea, R., Brain, H., Whitehead, S. A., & Mason, H. D. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1582 · Cited by 518
Theca: the forgotten cell of the ovarian follicle
Young, J. M., & McNeilly, A. S. (2010) · Reproduction · doi:10.1530/rep-10-0094 · Cited by 516
Jonard, S. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh010 · Cited by 513
Martin, K. A., Chang, R. J., Ehrmann, D. A., Ibáñez, L., Løbo, R. A., Rosenfield, R. L., Shapiro, J., Montori, V. M., & Swiglo, B. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2437 · Cited by 511
Self-citationIbáñez, L., Potau, N., François, I., & de Zegher, F. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5205 · Cited by 509
Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences*
Fauser, B. C. J. M., & van Heusden, A. M. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0290 · Cited by 509
EHRMAN, D. A., Barnes, R. B., & Rosenfield, R. L. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-322 · Cited by 498
Self-citationAromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis
Simpson, E. R. (1994) · Endocrine Reviews · doi:10.1210/er.15.3.342 · Cited by 482
Hayes, M. G., Urbanek, M., Ehrmann, D. A., Armstrong, L. L., Lee, J. Y., Sisk, R., Karaderi, T., Barber, T. M., McCarthy, M. I., Franks, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8502 · Cited by 478
Self-citationUrbanek, M., Legro, R. S., Driscoll, D. A., Azziz, R., Ehrmann, D. A., Norman, R. J., Strauss, J. F., Spielman, R. S., & Dunaif, A. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8573 · Cited by 477
Self-citationPremature Adrenarche - A Common Condition with Variable Presentation
Utriainen, P., Laakso, S. M., Liimatta, J., Jääskeläinen, J., & Voutilainen, R. (2015) · Hormone Research in Paediatrics · doi:10.1159/000369458 · Cited by 477
Ehrmann, D. A., Schneider, D. J., Sobel, B. E., Cavaghan, M. K., Imperial, J., Rosenfield, R. L., & Polonsky, K. S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4069 · Cited by 461
Self-citationDunaif, A. E., & Finegood, D. T. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772555 · Cited by 454
Coviello, A. D., Legro, R. S., & Dunaif, A. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1666 · Cited by 446
Carmina, E., Koyama, T., Chang, L., Stanczyk, F. Z., & Løbo, R. A. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91779-a · Cited by 441
Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries
Gilling‐Smith, C., Willis, D., Beard, R. W., & Franks, S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962289 · Cited by 436
Pasquali, R., Antenucci, D., Casimirri, F., Venturoli, S., Paradisi, R., Fabbri, R., Balestra, V., Melchionda, N., & Barbara, L. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-1-173 · Cited by 436
Morphology and Morphogenesis of the Stein-Leventhal Ovary and of So-called “Hyperthecosis”
Hughesdon, P. E. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198202000-00001 · Cited by 429
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Escobar-Morreale, H. F., Luque‐Ramírez, M., & Millán, J. L. S. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0004 · Cited by 426
Ehrmann, D. A., Sturis, J., Byrne, M. M., Karrison, T., Rosenfield, R. L., & Polonsky, K. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118064 · Cited by 426
Self-citationBurger, H., Hale, G. E., Robertson, D. M., & Dennerstein, L. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm020 · Cited by 421
Carmina, E., Rosato, F., Jannì, A., Rizzo, M., & Longo, R. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1457 · Cited by 420
Eagleson, C. A., Gingrich, M. B., Pastor, C. L., Arora, T. K., Solorzano, C. M. B., Evans, W. S., & Marshall, J. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6992 · Cited by 413
Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS
Kahsar-Miller, M. D., Nixon, C., Boots, L. R., Go, R. C., & Azziz, R. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01662-9 · Cited by 406
Nelson, V. L., Qin, K.-N., Rosenfield, R. L., Wood, J. R., Penning, T. M., Legro, R. S., Strauss, J. F., & McAllister, J. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8088 · Cited by 405
Self-citationCimino, I., Casoni, F., Liu, X., Messina, A., Parkash, J., Jamin, S. P., Catteau-Jonard, S., Collier, F., Baroncini, M., Dewailly, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms10055 · Cited by 404
Kandaraki, E., Chatzigeorgiou, A., Livadas, S., Palioura, E., Economou, F., Koutsilieris, M., Palimeri, S., Panidis, D., & Diamanti‐Kandarakis, E. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1658 · Cited by 402
Horton, R., & Tait, J. F. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105344 · Cited by 401
Lee, M., Pramyothin, P., Karastergiou, K., & Fried, S. K. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.029 · Cited by 399
Ehrmann, D. A. (1995) · Endocrine Reviews · doi:10.1210/er.16.3.322 · Cited by 394
Self-citationYen, S. S. C., VELA, P., & RANKIN, J. (1970) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-30-4-435 · Cited by 391
Gonadotropic control of ovarian follicular growth and development
Hillier, S. G. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00469-5 · Cited by 390
Escobar-Morreale, H. F., Botella-Carretero, J. I., Álvarez‐Blasco, F., Sancho, J., & Millán, J. L. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1490 · Cited by 389
Reyes, F. I., Boroditsky, R. S., Winter, J. S. D., & Faiman, C. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-4-612 · Cited by 385
Induction of insulin resistance by androgens and estrogens
Polderman, K. H., Gooren, L. J., Asscheman, H., Bakker, A., & Heine, R. J. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.1.8027240 · Cited by 382
Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline
Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10915 · Cited by 379
Zouboulis, C., Chen, W.-C., Thornton, M., Qin, K., & Rosenfield, R. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-961807 · Cited by 379
Self-citationVgontzas, A. N., Legro, R. S., Bixler, E. O., Grayev, A., Kales, A., & Chrousos, G. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7185 · Cited by 371
Willis, D., Mason, H., Gilling-Smith, C., & Franks, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550768 · Cited by 371
Puberty decreases insulin sensitivity
Bloch, C., Clemons, P., & Sperling, M. A. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80522-x · Cited by 370
Tang, T. H., Norman, R. J., Balen, A. H., & Lord, J. M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053 · Cited by 369
The Polycystic Ovary. I. Clinical and Histologic Features
Goldzieher, J. W., & Green, J. (1962) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-22-3-325 · Cited by 369
Mannerås-Holm, L., Leonhardt, H., Kullberg, J., Jennische, E., Odén, A., Holm, G., Hellström, M., Lönn, L., Olivecrona, G., Stener-Victorin, E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1290 · Cited by 369
Broussard, J. L., Ehrmann, D. A., Van Cauter, E., Tasali, E., & Brady, M. J. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-8-201210160-00005 · Cited by 364
Self-citationWeil, S. J., Vendola, K., Zhou, J., Adesanya, O. O., Wang, J., Okafor, J., & Bondy, C. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4917 · Cited by 359
Ibañez, L., Potau, N., Virdis, R., Zampolli, M., Terzi, C., Gussinyé, M., Carrascosa, A., & Vicens-Calvet, E. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501168 · Cited by 341
Cellular mechanisms of insulin resistance in polycystic ovarian syndrome
Ciaraldi, T. P. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.2.577 · Cited by 336
Tang, T., Glanville, J., Hayden, C. J., White, D., Barth, J. H., & Balen, A. H. (2006) · Human Reproduction · doi:10.1093/humrep/dei311 · Cited by 335
Lauritsen, M. P., Bentzen, J. G., Pinborg, A., Loft, A., Forman, J. L., Thuesen, L. L., Cohen, A., Hougaard, D. M., & Nyboe Andersen, A. (2014) · Human Reproduction · doi:10.1093/humrep/det469 · Cited by 334
Cara, J. F., & Rosenfield, R. L. (1988) · Endocrinology · doi:10.1210/endo-123-2-733 · Cited by 333
Self-citationBuse, J. B., DeFronzo, R. A., Rosenstock, J., Kim, T., Burns, C., Skare, S., Baron, A., & Fineman, M. (2016) · Diabetes Care · doi:10.2337/dc15-0488 · Cited by 325
Detection of Functional Ovarian Hyperandrogenism in Women with Androgen Excess
Ehrmann, D. A., Rosenfield, R. L., Barnes, R. B., Brigell, D. F., & Sheikh, Z. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207163270304 · Cited by 322
Self-citationThe association between pregnancy weight gain and birthweight: a within-family comparison
Ludwig, D. S., & Currie, J. L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60751-9 · Cited by 321
Sen, A., & Hammes, S. R. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0006 · Cited by 313
Willis, D., Watson, H., Mason, H. D., Galea, R., Brincat, M., & Franks, S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5232 · Cited by 312
Wood, J. R., Dumesic, D. A., Abbott, D. H., & Strauss, J. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2123 · Cited by 310
Pituitary-Ovarian Responses to Nafarelin Testing in the Polycystic Ovary Syndrome
Barnes, R. B., Rosenfield, R. L., Burstein, S., & Ehrmann, D. A. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200904 · Cited by 308
Self-citationRosenfield, R. L. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp033496 · Cited by 304
Self-citationBarnes, R. B., Rosenfield, R. L., Ehrmann, D. A., Cara, J. F., Cuttler, L., Levitsky, L. L., & Rosenthal, I. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962325 · Cited by 304
Self-citationEvidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome
Gilling‐Smith, C., Story, H., Rogers, V., & Franks, S. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2321049.x · Cited by 301
Baillargeon, J.-P., Jakubowicz, D. J., Iuorno, M. J., Jakubowicz, S., & Nestler, J. E. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.02.127 · Cited by 300
Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome
Lewy, V. D., Danadian, K., Witchel, S. F., & Arslanian, S. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.109603 · Cited by 298
Barbieri, R. L., & Ryan, K. J. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90091-1 · Cited by 295
Chen, Y.-H., Heneidi, S. G., Lee, J.-M., Layman, L. C., Stepp, D. W., Gamboa, G. M., Chen, B.-S., Chazenbalk, G. D., & Azziz, R. (2013) · Diabetes · doi:10.2337/db12-0963 · Cited by 291
Kirchengast, S. (2001) · Human Reproduction · doi:10.1093/humrep/16.6.1255 · Cited by 291
Identifying Children at Risk for Polycystic Ovary Syndrome
Rosenfield, R. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2012 · Cited by 288
Self-citationEagleson, C. A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.11.4047 · Cited by 286
Evidence for a single gene effect causing polycystic ovaries and male pattern baldness
Carey, A. H., Chan, K., Short, F., White, D. M., Williamson, R., & Franks, S. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02150.x · Cited by 285
Corbould, A., Kim, Y.-B., Youngren, J. F., Pender, C., Kahn, B. B., Lee, A., & Dunaif, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2004 · Cited by 283
Robinson, S., Kiddy, D. S., Gelding, S. V., Willis, D., Niththyananthan, R., Bush, A., Johnston, D. G., & Franks, S. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02376.x · Cited by 282
O’Reilly, M., TAYLOR, A. E. R., Crabtree, N. J., Hughes, B. A., Capper, F., Crowley, R. K., Stewart, P. M., Tomlinson, J., & Arlt, W. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3399 · Cited by 279
Diagnosis of Polycystic Ovarian Syndrome: In Defense of the Rotterdam Criteria
Franks, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2501 · Cited by 278
11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess
Morgan, S., McCabe, E. L., Gathercole, L., Hassan-Smith, Z. K., Larner, D. P., Bujalska, I. J., Stewart, P. M., Tomlinson, J., & Lavery, G. G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323681111 · Cited by 273
Yıldız, B. O., Yaralı́, H., Oğuz, H., & Bayraktar, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021499 · Cited by 273
Arslanian, S. A., Lewy, V., Danadian, K., & Saad, R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8398 · Cited by 272
Huber-Buchholz, M.-M. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.4.1470 · Cited by 269
Persani, L., Rossetti, R., Pasquale, E. D., Cacciatore, C., & Fabre, S. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu036 · Cited by 268
Dissecting human adrenal androgen production
Rainey, W. E., Carr, B. R., Sasano, H., Suzuki, T., & Mason, J. I. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00609-4 · Cited by 268
Pastor, C. L., Griffin-Korf, M. L., Aloi, J. A., Evans, W. S., & Marshall, J. C. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4604 · Cited by 263
Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome
Harborne, L., Fleming, R., Lyall, H., Norman, J. E., & Sattar, N. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13493-9 · Cited by 262
Androgen Actions and the Ovary
Walters, K. A., Allan, C. M., & Handelsman, D. J. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.107.064089 · Cited by 262
Sir-Petermann, T., Codner, E., Pérez, V., Echiburú, B., Maliqueo, M., Ladrón de Guevara, A., Preisler, J., Crisosto, N., Sánchez, F., Cassorla, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2836 · Cited by 260
Liu, C., Jia, P., Matzuk, M. M., & Yao, H. H. (2015) · Nature Communications · doi:10.1038/ncomms7934 · Cited by 257
Jakimiuk, A. J., Weitsman, S. R., Navab, A., & Magoffin, D. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7318 · Cited by 256
Barber, T. M., Wass, J. A. H., McCarthy, M. I., & Franks, S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02764.x · Cited by 254
Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype
McAllister, J. M., Modi, B., Miller, B. A., Biegler, J., Bruggeman, R., Legro, R. S., & Strauss, J. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400574111 · Cited by 250 · cited 3×
“V2 in PCOS theca cells reduced androgen biosynthesis and CYP17A1 and CYP11A1 gene expression” (108).”
BackgroundToward Excellence in Testosterone Testing: A Consensus Statement
Rosner, W., & Vesper, H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1314 · Cited by 248
Farquhar, C. M., Birdsall, M. A., Manning, P. J., Mitchell, J., & France, J. T. (1994) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1994.tb01041.x · Cited by 246
Bélanger, C., Luu-The, V., Dupont, P., & Tchernof, A. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-38265 · Cited by 246
Jeppesen, J. V., Kristensen, S. G., Nielsen, M. E., Humaidan, P., Canto, M. D., Fadini, R., Schmidt, K. T., Ernst, E., & Andersen, C. Y. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1427 · Cited by 244
Legro, R. S., Dodson, W. C., Kris-Etherton, P. M., Kunselman, A. R., Stetter, C. M., Williams, N. I., Gnatuk, C. L., Estes, S. J., Fleming, J., Allison, K. C., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2778 · Cited by 242
Fetal growth, length of gestation, and polycystic ovaries in adult life
Cresswell, J., Barker, D., Osmond, C., Egger, P., Phillips, D., & Fraser, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06062-5 · Cited by 241
Jain, A., Polotsky, A. J., Rochester, D., Berga, S. L., Loucks, T. L., Zeitlian, G., Gibbs, K. E., Polotsky, H. N., Feng, S., Isaac, B., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2274 · Cited by 234
Functional genomics of PCOS: from GWAS to molecular mechanisms
McAllister, J. M., Legro, R. S., Modi, B. P., & Strauss, J. F. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.12.004 · Cited by 227
Rege, J., Nakamura, Y., Satoh, F., Morimoto, R., Kennedy, M. R., Layman, L. C., Honma, S., Sasano, H., & Rainey, W. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2912 · Cited by 227
ROSENBAUM, D. S., Haber, R. S., & Dunaif, A. E. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.2.e197 · Cited by 223
Placental steroidogenesis in pregnant women with polycystic ovary syndrome
Maliqueo, M. A., Lara, H. E., Sánchez, F., Echiburú, B., Crisosto, N., & Sir‐Petermann, T. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2012.10.015 · Cited by 223
Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome
Rl, R., Barnes, R., Cara, J., & Lucky, A. W. (1991) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(91)90373-d · Cited by 222
Govind, A., Obhrai, M. S., & Clayton, R. N. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5382 · Cited by 219
Endoh, A., Kristiansen, S. B., Casson, P. R., Buster, J. E., & Hornsby, P. J. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855801 · Cited by 219
Transcriptional regulation of steroid hydroxylase genes by corticotropin
John, M. E., John, M. C., Boggaram, V, Simpson, E. R., & Waterman, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4715 · Cited by 217
Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?
Sverrisdóttir, Y. B., Mogren, T., Kataoka, J., Janson, P. O., & Stener-Victorin, E. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00725.2007 · Cited by 216
Taylor, A. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.7.2248 · Cited by 214
Legro, R. S., Schlaff, W. D., Diamond, M. P., Coutifaris, C., Casson, P. R., Brzyski, R. G., Christman, G. M., Trussell, J. C., Krawetz, S. A., Snyder, P. J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1123 · Cited by 213
Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass
Eid, G. M., Cottam, D. R., Velcu, L. M., Mattar, S. G., Korytkowski, M. T., Gosman, G. G., Hindi, P., & Schauer, P. R. (2005) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2005.02.008 · Cited by 208
Willis, D. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.11.3984 · Cited by 207
Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome
Rosenfield, R. L., Barnes, R. B., Cara, J. F., & Lucky, A. W. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53510-9 · Cited by 206
Self-citationClinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
Guastella, E., Longo, R. A., & Carmina, E. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.02.014 · Cited by 205
Willis, D., & Franks, S. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530637 · Cited by 203
Mason, H. D., Willis, D., Beard, R. W., Winston, R. M. L., Margara, R. A., & Franks, S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962330 · Cited by 201
The Diagnosis of Polycystic Ovary Syndrome in Adolescents
Rosenfield, R. L. (2015) · PEDIATRICS · doi:10.1542/peds.2015-1430 · Cited by 201
Self-citationJohnstone, E. B., Rosen, M. P., Neril, R., Trevithick, D., Sternfeld, B., Murphy, R. C., Addauan-Andersen, C., McConnell, D. S., Pera, R. A. R., & Cedars, M. I. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0202 · Cited by 200
Selective Insulin Resistance in the Polycystic Ovary Syndrome
Book, C. B., & Dunaif, A. E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.6010 · Cited by 199
Goodarzi, M. O., Carmina, E., & Azziz, R. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.06.003 · Cited by 197
Quinkler, M. O., Sinha, B., Tomlinson, J., Bujalska, I. J., Stewart, P. M., & Arlt, W. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05762 · Cited by 195
Postnatal Developmental Changes in the Pituitary-Ovarian Axis in Preterm and Term Infant Girls
Kuiri‐Hänninen, T., Kallio, S., Seuri, R. M., Tyrväinen, E., Liakka, A., Tapanainen, J. S., Sankilampi, U., & Dunkel, L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1502 · Cited by 194
Pache, T. D., Chadha, S., Gooren, L. J., Hop, W. C. J., JAARSMA, K. W., Dommerholt, H. B. R., & Fauser, B. C. J. M. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00235.x · Cited by 194
Histopathological Effects of Exogenously Administered Testosterone in 19 Female to Male Transsexuals
Futterweit, W., & Deligdisch, L. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-1-16 · Cited by 194
Referral Bias in Defining the Phenotype and Prevalence of Obesity in Polycystic Ovary Syndrome
Ezeh, U., Yildiz, B. O., & Azziz, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1295 · Cited by 193
The Endocrine function of the human adrenal cortex
James, V. H. T. (1978) · Academic Press eBooks · Cited by 191
Luteinizing Hormone Beta Mutation and Hypogonadism in Men and Women
Lofrano‐Porto, A., Barra, G. B., Giacomini, L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071999 · Cited by 191
Androgen production and metabolism in normal and virilized women
Kirschner, M. A., & Bardin, C. W. (1972) · Metabolism · doi:10.1016/0026-0495(72)90090-x · Cited by 191
Taponen, S., Martikainen, H. K., Järvelin, M., Laitinen, J. H., Pouta, A. M., Hartikainen, A., Sovio, U., McCarthy, M. I., Franks, S., & Ruokonen, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020982 · Cited by 190
Reproductive and Metabolic Phenotype of a Mouse Model of PCOS
van Houten, E. L. A. F., Kramer, P., McLuskey, A., Karels, B., Themmen, A. P. N., & Visser, J. A. (2012) · Endocrinology · doi:10.1210/en.2011-1754 · Cited by 190
Myo-inositol in patients with polycystic ovary syndrome: A novel method for ovulation induction
Papaleo, E., Unfer, V., Baillargeon, J., Santis, L. D., Fusi, F., Brigante, C., Marelli, G., Cino, I., Redaelli, A., & Ferrari, A. G. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701672405 · Cited by 188
Inappropriate Gonadotropin Secretion in Polycystic Ovary Syndrome: Influence of Adiposity 1
Arroyo, A., Laughlin, G. A., Morales, A. J., & Yen, S. S. C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4377 · Cited by 186
Flagged first, then by citations
Research works printed but not linked: 12
- Rosenfield, 1992, Ovarian steroidogenic abnormalities in polycystic ovary syndrome: evidence for abnormal coordinate regulation of androgen and estrogen secretion, 83
- Zawadzki, 1992, Diagnostic criteria for polycystic ovary syndrome: towards a rational approach, 377
- Johnson T , KaplanL, OuyangP, RizzaR. National Institutes of Health evidence-based methodology workshop on polycystic ovary syndrome (PCOS). NIH EbMW Report. 2013. Available from https://prevention.nih.gov/programs-events/pathways-to-prevention/previous-workshops/pcos/workshop-resources. Bethesda, MD: National Institutes of Health; 1–14.
- Hoffman, 1965, [On the action of intraovarian injection of androgen on follicle and corpus luteum maturation in women], Geburtshilfe Frauenheilklinic, 25, 1132
- Mills, 1962, The relationship between the production of cortisol and androgen by the human adrenal
- Grumbach, 1978, Clinical disorders of adrenal function and puberty: an assessment of the role of the adrenal cortex in normal and abnormal puberty in man and evidence for an ACTH-like pituitary adrenal androgen stimulating hormone, 583
- Rosenfield, 1983, The role of proteins in the distribution of plasma androgens and estradiol, 25
- Rosenfield, 2015, Hyperandrogenism, hirsutism, and the polycystic ovary syndrome, 2275
- Barnes, 1993, Ovarian steroidogenic responses to the gonadotropin-releasing hormone agonist nafarelin in hirsute women thought to have 3β-hydroxysteroid dehydrogenase deficiency, J Clin Endocrinol Metab, 76, 450
- Varlamov, 2016, Hyperandrogenemia induces adipose tissue dysfunction in adolescent female rhesus macaques consuming a western-style diet, Endocr Rev, 37
- Marti, 2016, The backdoor androgen biosynthesis pathway exists in the human ovary and seems altered in PCOS, Endocr Rev, 37
- Caprio, 1994, Developmental changes in insulin action and secretion in childhood health and disease, Adv Endocrinol Metab, 5, 171
Cited by
Sorted by citations
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479371 · Cited by 463
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Zhao, X., Wang, M., Wen, Z., Lu, Z., Cui, L., Fu, C., Xue, H., Liu, Y., & Zhang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721135 · Cited by 463
Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics
Glueck, C. J., & Goldenberg, N. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.002 · Cited by 442
Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
Sadeghi, H. M., Adeli, I., Calina, D., Docea, A. O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A., & Abdollahi, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020583 · Cited by 445
Metadata
- Authors
- Rosenfield, R. L., & Ehrmann, D. A.
- Affiliations
- University of Chicago (US)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2016-07-26
- Volume
- 37
- Issue
- 5
- Pages
- 467-520
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC5045492
- OpenAlex
- W2528009933
- Cited by
- 1,603
- References
- 549
- Citations by year
- 2026: 201 · 2025: 234 · 2024: 207 · 2023: 229 · 2022: 224 · 2021: 191 · 2020: 137 · 2019: 87 · 2018: 56 · 2017: 33 · 2016: 2
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Chicago (UL1 RR024999)
- National Institutes of Health (P60 DK20595)
- National Institute of Diabetes and Digestive and Kidney Diseases (P60DK020595, P30DK020595)
- National Institute of Child Health and Human Development
- National Center for Research Resources (RR-00055, UL1RR024999, M01RR000055)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD057796)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- polycystic ovary syndrome, androgen secretion, theca cells, P450c17, insulin resistance, hyperinsulinemia, metabolic syndrome, obesity, prenatal androgen exposure, fetal growth restriction, hyperandrogenemia
- MeSH terms
- Androgens, Animals, Female, Humans, Hyperinsulinism, Insulin Resistance, Ovary, Polycystic Ovary Syndrome, Hyperandrogenism, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
